Gå direkt till innehåll

Kategorier: codiak biosciences

  • Codiak BioSciences applies for an IPO listning at Nasdaq NY

    Codiak BioSciences applies for an IPO listning at Nasdaq NY

    Codiak BioSciences, a company developing therapies based on tiny bubbles secreted by cells, is lining up an IPO as it prepares for the first tests of its technology in humans later this year. In paperwork filed with securities regulators late Wednesday, Codiak set a preliminary $100 million goal for its stock market debut.